Pharma Journalist -

Emergent BioSolutions Inc. announced that it has entered into an agreement with Vaxart, Inc. a clinical-stage biotechnology company, whereby Emergent has agreed to utilize its…
Read More...

Roche announced we are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with…
Read More...

IMV Inc. announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio) announced that it has entered into a research collaboration and licensing agreement with the University of North Carolina at Chapel Hill (UNC)…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based…
Read More...

Merck, known as MSD outside the United States and Canada, announced top-line efficacy results from two ongoing pivotal Phase 3 trials (COUGH-1 and COUGH-2) evaluating the efficacy and…
Read More...

High-level results from the final analysis of the Phase III CASPIAN trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of standard-of-care (SoC) chemotherapies…
Read More...

RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical…
Read More...

Conference Chair shares his views on the HPAPI industry for the upcoming Highly Potent Active Pharmaceutical Ingredients conference SMi Group’s Highly Potent Active Pharmaceutical…
Read More...